A biosensor for the activity of the "sheddase" TACE (ADAM17) reveals novel and cell type-specific mechanisms of TACE activation

Science Signaling

Volumn 8, Issue 365, 2015, Pages

  Chapnick, Douglas A ^a   Bunker, Eric ^a   Liu, Xuedong ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROTRIANISENE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; TRANSFORMING GROWTH FACTOR ALPHA; ADAM PROTEIN; TUMOR NECROSIS FACTOR-ALPHA CONVERTASE;

ACTIN FILAMENT; ARTICLE; BIOSENSOR; CELL ACTIVATION; CELL ACTIVITY; CELL LINE; CELL MEMBRANE; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMAN; HUMAN CELL; KERATINOCYTE; KINETICS; PRIORITY JOURNAL; ANIMAL; CYTOLOGY; CYTOSKELETON; ENZYME ACTIVATION; ENZYMOLOGY; GENETIC PROCEDURES; GENETICS; KNOCKOUT MOUSE; METABOLISM; MOUSE; PROCEDURES; SIGNAL TRANSDUCTION;

ADAM PROTEINS; ANIMALS; BIOSENSING TECHNIQUES; CYTOSKELETON; ENZYME ACTIVATION; EPITHELIAL CELLS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FLUORESCENCE RESONANCE ENERGY TRANSFER; KERATINOCYTES; MAP KINASE SIGNALING SYSTEM; MICE; MICE, KNOCKOUT; P38 MITOGEN-ACTIVATED PROTEIN KINASES; TRANSFORMING GROWTH FACTOR ALPHA;

EID: 84923652161     PISSN: 19450877     EISSN: 19379145     Source Type: Journal    
DOI: 10.1126/scisignal.2005680     Document Type: Article

References (44)

1. Y. Li, J. Brazzell, A. Herrera, B. Walcheck, ADAM17 deficiency by mature neutrophils has differential effects on L-selectin shedding. Blood 108, 2275-2279 (2006).
2. R. A. Black C. T. Rauch, C. J. Kozlosky, J. J. Peschon, J. L. Slack, M. F. Wolfson, B. J. Castner, K. L. Stocking, P. Reddy, S. Srinivasan, N. Nelson, N. Boiani, K. A. Schooley, M. Gerhart, R. Davis, J. N. Fitzner, R. S. Johnson, R. J. Paxton, C. J. March, D. P. Cerretti, A metalloproteinase disintegrin that releases tumour-necrosis factor- A from cells. Nature 385, 729-733 (1997).
3. T. Maretzky, A. Evers, W. Zhou, S. L. Swendeman, P. M. Wong, S. Rafii, K. Reiss, C. P. Blobel, Migration of growth factor-stimulated epithelial and endothelial cells depends on EGFR trans activation by ADAM17. Nat. Commun. 2, 229 (2011).
4. E. L. Hassemer, B. Endres, J. A. Toonen, A. Ronchetti, R. Dubielzig, D. J. Sidjanin, ADAM17 trans activates EGFR signaling during embryonic eyelid closure. Invest. Ophthalmol. Vis. Sci. 54, 132-140 (2013).
5. O. Giricz, V. Calvo, E. A. Peterson, C. M. Abouzeid, P. A. Kenny, TACE-dependent TGFa shedding drives triple-negative breast cancer cell invasion. Int. J. Cancer 133, 2587-2595 (2013).
6. J. Scheller, A. Chalaris, C. Garbers, S. Rose-John, ADAM17: A molecular switch to control inflammation and tissue regeneration. Trends Immunol. 32, 380-387 (2011).
7. D. C. Lee, S. W. Sunnarborg, C. L. Hinkle, T. J. Myers, M. Y. Stevenson, W. E. Russell, B. J. Castner, M. J. Gerhart, R. J. Paxton, R. A. Black, A. Chang, L. F. Jackson, TACE/ADAM17 processing of EGFR ligands indicates a role as a physiological convertase. Ann N. Y. Acad. Sci. 995, 22-38 (2003).
8. Y. Nakamura, C. Sotozono, S. Kinoshita, The epidermal growth factor receptor (EGFR): Role in corneal wound healing and homeostasis. Exp. Eye Res. 72, 511-517 (2001).
9. A. Wells, Tumor invasion: Role of growth factor-induced cell motility. Adv. Cancer Res. 78, 31-101 (2000).
10. C. P. Blobel, ADAMs: Key components in EGFR signalling and development. Nat. Rev. Mol. Cell Biol. 6, 32-43 (2005).
11. M. A. Miller, A. S. Meyer, M. T. Beste, Z. Lasisi, S. Reddy, K.W. Jeng, C. H. Chen, J. Han, K. Isaacson, L. G. Griffith, D. A. Lauffenburger, ADAM-10 and -17 regulate endometriotic cell migration via concerted ligand and receptor shedding feedback on kinase signaling. Proc. Natl. Acad. Sci. U.S.A. 110, E2074-E2083 (2013).
12. S. M. Le Gall, P. Bobe, K. Reiss, K. Horiuchi, X. D. Niu, D. Lundell, D. R. Gibb, D. Conrad, P. Saftig, C. P. Blobel, ADAMs 10 and 17 represent differentially regulated components of a general shedding machinery for membrane proteins such as transforming growth factor a, L-selectin, and tumor necrosis factor a. Mol. Biol. Cell 20, 1785-1794 (2009).
13. C. Adrain, M. Zettl, Y. Christova, N. Taylor, M. Freeman, Tumor necrosis factor signaling requires iRhom2 to promote trafficking and activation of TACE. Science 335, 225-228 (2012).
14. G. Murphy, Regulation of the proteolytic disintegrin metalloproteinases, the "Sheddases". Semin. Cell Dev. Biol. 20, 138-145 (2009).
15. P. E. Gonzales, A. Solomon, A. B. Miller, M. A. Leesnitzer, I. Sagi, M. E. Milla, Inhibition of the tumor necrosis factor-a-converting enzyme by its pro domain. J. Biol. Chem. 279, 31638-31645 (2004).
16. N. Srour, A. Lebel, S. McMahon, I. Fournier, M. Fugere, R. Day, C. M. Dubois, TACE/ADAM-17 maturation and activation of sheddase activity require proprotein convertase activity. FEBS Lett. 554, 275-283 (2003).
17. S. M. Soond, B. Everson, D. W. Riches, G. Murphy, ERK-mediated phosphorylation of Thr735 in TNFa-converting enzyme and its potential role in TACE protein trafficking. J. Cell Sci. 118, 2371-2380 (2005).
18. P. Xu, R. Derynck, Direct activation of TACE-mediated ectodomain shedding by p38 MAP kinase regulates EGF receptor-dependent cell proliferation. Mol. Cell 37, 551-566 (2010).
19. E. Diaz-Rodriguez, J. C. Montero, A. Esparis-Ogando, L. Yuste, A. Pandiella, Extracellular signal-regulated kinase phosphorylates tumor necrosis factor a-converting enzyme at threonine 735: A potential role in regulated shedding. Mol. Biol. Cell 13, 2031-2044 (2002).
20. H. Fan, R. Derynck, Ectodomain shedding of TGF- A and other trans membrane proteins is induced by receptor tyrosine kinase activation and MAP kinase signaling cascades. EMBO J. 18, 6962-6972 (1999).
21. Z. Gechtman, J. L. Alonso, G. Raab, D. E. Ingber, M. Klagsbrun, The shedding of membrane-anchored heparin-binding epidermal-like growth factor is regulated by the Raf/mitogen-activated protein kinase cascade and by cell adhesion and spreading. J. Biol. Chem. 274, 28828-28835 (1999).
22. T. Maretzky, W. Zhou, X. Y. Huang, C. P. Blobel, A transforming Src mutant increases the bioavailability of EGFR ligands via stimulation of the cell-surface metalloproteinase ADAM17. Oncogene 30, 611-618 (2011).
23. Q. Zhang, S. M. Thomas, V. W. Lui, S. Xi, J. M. Siegfried, H. Fan, T. E. Smithgall, G. B. Mills, J. R. Grandis, Phosphorylation of TNF- A converting enzyme by gas trinreleasing peptide induces amphiregulin release and EGF receptor activation. Proc. Natl. Acad. Sci. U.S.A. 103, 6901-6906 (2006).
24. M. Ouyang, H. Huang, N. C. Shaner, A. G. Remacle, S. A. Shiryaev, A. Y. Strongin, R. Y. Tsien, Y. Wang, Simultaneous visualization of pro tumorigenic Src and MT1-MMP activities with fluorescence resonance energy transfer. Cancer Res. 70, 2204-2212 (2010).
25. G. P. Briley, M. A. Hissong, M. L. Chiu, D. C. Lee, The carboxyl-terminal valine residues of proTGF alpha are required for its efficient maturation and intracellular routing. Mol. Biol. Cell 8, 1619-1631 (1997).
26. M. J. Mohan, T. Seaton, J. Mitchell, A. Howe, K. Blackburn, W. Burkhart, M. Moyer, I. Patel, G. M. Waitt, J. D. Becherer, M. L. Moss, M. E. Milla, The tumor necrosis factor- A converting enzyme (TACE): A unique metalloproteinase with highly defined substrate selectivity. Biochemistry 41, 9462-9469 (2002).
27. G. Jin, X. Huang, R. Black, M. Wolfson, C. Rauch, H. McGregor, G. Ellestad, R. Cowling, A continuous fluorimetric assay for tumor necrosis factor- A converting enzyme. Anal. Bio chem. 302, 269-275 (2002).
28. M. Lelimousin, M. Noirclerc-Savoye, C. Lazareno-Saez, B. Paetzold, S. Le Vot, R. Chazal, P. Macheboeuf, M. J. Field, D. Bourgeois, A. Royant, Intrinsic dynamics in ECFP and Cerulean control fluorescence quantum yield. Biochemistry 48, 10038-10046 (2009).
29. M. Grootveld, M. F. McDermott, BMS-561392. Bristol-Myers Squibb. Curr. Opin. Investig. Drugs 4, 598-602 (2003).
30. J. Tucher, D. Linke, T. Koudelka, L. Cassidy, C. Tredup, R.Wichert, C. Pietrzik, C. Becker-Pauly, A. Tholey, LC-MS based cleavage site profiling of the proteases ADAM10 and ADAM17 using proteome-derived peptide libraries. J. Proteome Res. 13, 2205-2214 (2014).
31. M. Alvarez-Iglesias, G. Wayne, K. P. O'Dea, A. Amour, M. Takata, Continuous real-time measurement of tumor necrosis factor- A converting enzyme activity on live cells. Lab. Invest. 85, 1440-1448 (2005).
32. L. Armstrong, S. I. Godinho, K. M. Uppington, H. A. Whittington, A. B. Millar, Tumour necrosis factor- A processing in interstitial lung disease: A potential role for exogenous proteinase-3. Clin. Exp. Immunol. 156, 336-343 (2009).
33. J. Hu, P. E. Van den Steen, C. Dillen, G. Opdenakker, Targeting neutrophil collagenase/matrix metalloproteinase-8 and gelatinase B/matrix metalloproteinase-9 with a peptidomimetic inhibitor protects against endotoxin shock. Biochem. Pharmacol. 70, 535-544 (2005).
34. S. M. Le Gall, T. Maretzky, P. D. Issuree, X. D. Niu, K. Reiss, P. Saftig, R. Khokha, D. Lundell, C. P. Blobel, ADAM17 is regulated by a rapid and reversible mechanism that controls access to its catalytic site. J. Cell Sci. 123, 3913-3922 (2010).
35. Y. Wang, J. D. Robertson B. Walcheck, Different signaling pathways stimulate a disintegrin and metalloprotease-17 (ADAM17) in neutrophils during apoptosis and activation. J. Biol. Chem. 286, 38980-38988 (2011).
36. C. D. Harvey, A. G. Ehrhardt, C. Cellurale, H. Zhong, R. Yasuda, R. J. Davis, K. Svoboda, A genetically encoded fluorescent sensor of ERK activity. Proc. Natl. Acad. Sci. U.S.A. 105, 19264-19269 (2008).
37. S. Boulant, C. Kural, J. C. Zeeh, F. Ubelmann, T. Kirchhausen, Actin dynamics counteract membrane tension during clathrin-mediated endocytosis. Nat. Cell Biol. 13, 1124-1131 (2011).
38. L. C. Kelley, K. E. Hayes, A. G. Ammer, K. H. Martin, S. A. Weed, Cortactin phosphorylated by ERK1/2 localizes to sites of dynamic actin regulation and is required for carcinoma lamellipodia persistence. PLOS One 5, e13847 (2010).
39. M. Y. Han, H. Kosako, T. Watanabe, S. Hattori, Extracellular signal-regulated kinase/mitogen-activated protein kinase regulates actin organization and cell motility by phosphorylating the actin cross-linking protein EPLIN. Mol. Cell. Biol. 27, 8190-8204 (2007).
40. N. Martinez-Quiles, H. Y. Ho, M.W. Kirschner, N. Ramesh, R. S. Geha, Erk/Src phosphorylation of cortactin acts as a switch on-switch off mechanism that controls its ability to activate N-WASP. Mol. Cell. Biol. 24, 5269-5280 (2004).
41. L. C. Kelley, K. E. Hayes, A. G. Ammer, K. H. Martin, S. A.Weed, Revisiting the ERK/Src cortactin switch. Commun. Integr. Biol. 4, 205-207 (2011).
42. D. A. Chapnick, X. Liu, Leader cell positioning drives wound-directed collective migration in TGFb-stimulated epithelial sheets. Mol. Biol. Cell 25, 1586-1593 (2014).
43. D. L. Nikolic, A. N. Boettiger, D. Bar-Sagi, J. D. Carbeck, S. Y. Shvartsman, Role of boundary conditions in an experimental model of epithelial wound healing. Am. J. Physio. Cell. Physiol. 291, C68-C75 (2006).
44. N. Komatsu, K. Aoki, M. Yamada, H. Yukinaga, Y. Fujita, Y. Kamioka, M. Matsuda, Development of an optimized backbone of FRET biosensors for kinases and GTPases. Mol. Biol. Cell 22, 4647-4656 (2011).